Please Wait...

Kenneth Gaither

Translation skills

Main profile

Kenneth W Gaither, PhD.
Head of Musculoskeletal

Dr. Kenneth W Gaither has global responsibility leading the implementation and oversight of clinical trials for Bioclinica and has more than 20 years of experience in bone densitometry, body composition assessment, vertebral fracture and morphology methods, and structural geometry of bone within international multicenter clinical trials. He has published on these areas in peer-reviewed journals, and is a member of the American Society for Bone and Mineral Research and the International Society for Clinical Densitometry. Dr. Gaither received his Ph.D. in systems science with a focus on the utilization of simulation modeling for risk based systems. He has held director and vice president level positions within project management, data management, site selection and operations in a variety of healthcare industries including clinical research organizations, centralized imaging laboratories, and medical device manufacturers. Prior to Dr. Gaither’s career in healthcare, he served in the US Marine Corps as a signals intelligence officer and is a decorated veteran of foreign wars.

Authored Publications

Faulkner KG, McClung MR, Schmeer MS, Roberts LA, Gaither KW: Densitometry of the radius using single and dual energy absorptiometry.  Calc Tiss lnt 54:208-211.

Prevrhal S, Shepherd JA, Faulkner KG, Gaither KW, Lang TF: Validation of DXA Hip Structural Analysis Implementations with a QCT Volumetric Gold Standard. J Bone Min Res.2008 Apr-Jun; 11(2):232-6

Prevrhal S, Shepherd JA, Faulkner KG, Gaither KW, Black DM, Lang TF: Comparison of DXA Hip Structural Analysis with Volumetric QCT. J Clin Densitom . 2008 Feb:173(2):134-7.

Beck TJ, Fuerst T, Gaither KW, Sutradhar S, Levine AB, Hines T, Yu CR, Williams R, Mirkin S, Chines AA. The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis. Bone. April 23, 2015. Volume 77, Pages 115–119.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @MdFacep: FDA approvals: Merck's Keytruda wins FDA approval as combination therapy for kidney cancer. BIG! https://t.co/LgCzL1mvaF @Reu…
Bioclinica (11 hours ago)
RT @FDA_Drug_Info: National Prescription Drug Take Back Day is April 27, 2019 from 10:00 AM to 2:00 PM. Learn how to dispose of unused and…
Bioclinica (11 hours ago)
RT @iofbonehealth: #Osteoporosis Int: Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international…
Bioclinica (11 hours ago)
RT @HINJ_ORG: New Jersey's biopharmaceutical industry: CIANJ has assembled a panel of industry leaders @Celgene, @Bayer & @PhRMA to discuss…
Bioclinica (11 hours ago)
RT @PhRMA: Last year, the top 15 largest biopharmaceutical companies spent more than $100 billion on R&D, according to @IQVIA_global. More…
Bioclinica (11 hours ago)
RT @SCDM_DataDriven: Registrations for the SCDM 2019 Annual Conference are now open!! #SCDM2019 Register now for the biggest event in the…
Bioclinica (11 hours ago)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box